Cormorant Asset Management, LP

Cormorant Asset Management, LP is listed in filings as 10% Owner at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 30, 2026, including sale activity and purchase activity. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR), EyePoint Pharmaceuticals, Inc. (EYPT), Bright Minds Biosciences Inc. (DRUG), and Corbus Pharmaceuticals Holdings, Inc. (CRBP). The current snapshot covers public activity from Sep 24, 2024 to Apr 30, 2026. Reported amounts are shown as $48.2K to $942.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.